CMS Info Systems files DRHP for Rs.2,000 crore IPO

CMS
IPO
16/08/2021

In the latest in the string of big ticket IPOs, CMS Info Systems has filed draft red herring prospectus with SEBI for a proposed Rs.2,000 crore IPO. The entire IPO will be an offer sale by Sion Investment Holdings Pte Ltd, an affiliate of Baring Private Equity.

CMS Info Systems has been privately owned for more than 13 years now. In 2008, Blackstone took controlling stake in CMS Info Systems which was later sold to Baring Private Equity in 2015. Currently, Sion Investment Holdings owns 100% stake in the company.

CMS Info Systems is predominantly involved in tech-enabled banking support services. Its revenues basically come from ATM and Cash Management, ATM installations, ATM maintenance services and personalized card services. While cash management accounts for 68.6% of revenues, managed services accounts for 27.9% of yearly revenues.

India is the third largest ATM market in the world in terms of installed ATMs and CMS has a leadership position in ATM and cash management. CMS manages over Rs.5,000 crore of cash per day and operates through an all-India network of 3,911 cash vans, 224 offices and services over 133,000 business points on an average.

For the fiscal year ending March 2021, CMS reported net sales revenues of Rs.1,322 crore and net profits of Rs.169 crore implying net profit margins of 12.78%. The company has appointed Axis Capital, Jefferies India, JM Financial and DAM Capital (formerly IDFC Securities) as BRLMs for the issue.

Interestingly, Baring had tried to do an IPO in 2017 but decided to withhold the idea after market conditions turned unfavourable. This is their second attempt at taking the company public. Being a total offer for sale (OFS), there will not be any fresh funds coming into the company.

Next Article

Exxaro Tiles IPO lists at 5% premium, remains rangebound

Exxaro
IPO
16/08/2021

The expectations were not too huge as the fall in GMP had hinted at a tepid listing. Exxaro not only had a tepid listing, but also remained in a range through the day. On 16 August, Exxaro Tiles listed at a premium of just 5% and managed to hold above its issue price of Rs.120, through the day.  With overall subscription of over 22.65X in the IPO, and retail subscription at over 40.05X, the listing response was relatively muted. Here is the Exxaro Tiles IPO listing story on 16 August.

The IPO price was fixed at the upper end of the band at Rs.120 after the 22.65X subscription. On 16 Aug, the stock of Exxaro Tiles listed on the NSE at a price of Rs.126, a premium of 5% over the issue price. On the BSE also, the stock listed at a price of Rs.126, representing listing premium of 5%.

On the NSE, Exxaro Tiles closed at Rs.132.30, a first day closing premium of 10.25% over the issue price. On the BSE, the stock closed at Rs.132.25, a first day closing premium of 10.21% over the issue price. The stock held on to gains through the day.

On Day-1 of listing, Exxaro Tiles touched a high of Rs.132.30 on the NSE and a low of Rs.126. On Day-1, the Exxaro Tiles stock traded a total of 46.33 lakh shares on NSE amounting to value of Rs.59.74 crore.  On the NSE, Exxaro closed at its highest point of the day.

On the BSE, Exxaro Tiles touched a high of Rs.132.30 and a low of Rs.126. On BSE, the stock traded a total of 7.41 lakh shares amounting to value of Rs.9.56 crore. At the close of Day-1, Exxaro Tiles had a market capitalization of Rs.592 crore with free-float market cap of just Rs.154 crore.

 

Check:

1. Upcoming IPOs in 2021

2. Upcoming IPOs in August 2021

3. List of Forthcoming IPOs

Next Article

Windlas Biotech IPO Listing

Windlas
IPO
16/08/2021

Windlas Biotech had a discouraging listing on 16 August as it listed at a discount to the issue price and during the day the discount only widened. The sharp fall in the GMP was already indicative of a weak listing, but the actual listing was below what the GMP had indicated. Windlas Biotech listed at a discount of -5% and traded through the day below the issue price of Rs.460. In fact, even the high price of the day was well below the issue price. With overall subscription of over 22.44X, listing response was fairly discouraging. Here is the Windlas Biotech listing story on 16 August.

The Windlas Biotech IPO price was fixed at the upper end of the band at Rs.460 after the 22.44X subscription. On 16 Aug, the stock of Windlas Biotech listed on the NSE at a price of Rs.437, a discount of -5% on the issue price. On the BSE, the stock listed at a price of Rs.439, a listing discount of -4.6%.

On the NSE, Windlas Biotech closed at Rs.406, a first day closing discount of -11.74% on the issue price. On the BSE, the stock closed at Rs.406.70, a first day closing discount of -11.6% on the issue price.

On Day-1 of listing, Windlas Biotech touched a high of Rs.452 on the NSE and a low of Rs.405. On Day-1, the Windlas Biotech stock traded a total of 41.04 lakh shares on NSE amounting to value of Rs.174.35 crore. The stock closed near to the low of the day.

On the BSE, Windlas Biotech touched a high of Rs.452.10 and a low of Rs.405. On BSE, the stock traded a total of 3.27 lakh shares amounting to value of Rs.13.89 crore. At the close of Day-1, Windlas Biotech had a market capitalization of Rs.886 crore with free-float market cap of just Rs.248 crore.
 

 

Check:

1. Upcoming IPOs in 2021

2. Upcoming IPOs in August 2021

3. List of Forthcoming IPOs

Next Article

Devyani International IPO Listing

Devyani
IPO
16/08/2021

The expectations were huge as Devyani International had been subscribed more than 100 times in the IPO. The GMP was indicating a premium listing. While the listing was strong, the stock failed to hold on to higher levels. Devyani International listed at a premium of 56.6% but that turned out to be the high price for the day.  Despite overall subscription of 116.70X in the IPO consisting of HNI subscription at 213.06X and QIB subscription at 95.27X, the listing response tapered later. Here is the Devyani International listing story on 16 August.

The Devyani International IPO price was fixed at the upper end of the band at Rs.90 after the 116.70X subscription. On 16 Aug, the stock of Devyani International  listed on the NSE at a price of Rs.140.90, a hefty premium of 56.6% over the issue price. On the BSE, the stock is listed at a price of Rs.141, a listing premium of 56.7%.

On the NSE, Devyani International closed at Rs.122.60, a first-day closing premium of just about 36.2% over the issue price. On the BSE, the stock closed at Rs.123.35, a first-day closing premium of 37.1%. The opening price was almost the high price of the day.

On Day-1 of listing, Devyani International touched a high of Rs.140.90 on the NSE and a low of Rs.120.80. On Day-1, the Devyani International stock traded a total of 15.24 crore shares on NSE amounting to the value of Rs.1,989 crore. On the NSE, Devyani International was ranked Number 3 by traded value and traded volume on 16th August.

On the BSE, Devyani International touched a high of Rs.141.05 and a low of Rs.120.75. On BSE, the stock traded a total of 69.15 lakh shares amounting to the value of Rs.89.84 crore. At the close of Day-1, Devyani International had a market capitalization of Rs.14,833 crore with a free-float market cap of just Rs.1,632 crore.
 

 

Check:

1. Upcoming IPOs in 2021

2. Upcoming IPOs in August 2021

3. List of Forthcoming IPOs

Next Article

Krsnaa Diagnostics IPO listing

Krsna
IPO
16/08/2021

Krsnaa Diagnostics also had a tepid listing although it held on above the issue price. Krsnaa Diagnostics listed at a premium of just 5.4% but tapered further, managing to just hold above the issue price of Rs.954. With overall subscription of 64.38X in the IPO and with HNI subscription at 116.30X, the listing response was relatively muted. Here is the Krsnaa Diagnostics listing story on 16th August.

The Krsnaa Diagnostics IPO price was fixed at the upper end of the band at Rs.954 after 64.38X subscription. On 16th Aug, the stock of Krsnaa Diagnostics listed on the NSE at a price of Rs.1,005.55, a premium of 5.4% over the issue price. On the BSE, the stock listed at a price of Rs.1,025, a listing premium of 7.44%.

On the NSE, Krsnaa Diagnostics closed at Rs.978, a first day closing premium of just about 2.52% over the issue price. On the BSE, the stock closed at Rs.990.75, a first day closing premium of 3.85% over the issue price.

On Day-1 of listing, Krsnaa Diagnostics touched a high of Rs.1,099.70 on the NSE and a low of Rs.960. On Day-1, the Krsnaa Diagnostics stock traded a total of 83.08 lakh shares on NSE amounting to value of Rs.853.16 crore. On the NSE, Krsnaa Diagnostics was ranked Number 7 by traded value on 16th August.

On the BSE, Krsnaa Diagnostics touched a high of Rs.1,099.50 and a low of Rs.961.45. On BSE, the stock traded a total of 4.31 lakh shares amounting to value of Rs.44.21 crore. At the close of Day-1, Krsnaa Diagnostics had a market capitalization of Rs.3,111 crore with free-float market cap of just Rs.1,151 crore.

 

Check:

1. Upcoming IPOs in 2021

2. Upcoming IPOs in August 2021

3. List of Forthcoming IPOs

Next Article

CarTrade Tech IPO Allotment - How to Check the Allotment Status?

Car trade
IPO
17/08/2021

The Rs.2,999 crore IPO of CarTrade Tech, consisting entirely of an OFS of Rs.2,999 crore, was subscribed 20.29X overall at the close of bidding on 11 August. The basis of allotment will be finalized on 17 August. If you have applied for the IPO, you can check your allotment status online. 

 

What is the IPO allotment status?

IPO Allotment status indicates the number of shares/Stocks allocated against number of shares/Stocls applied for in an IPO. Allotment is categorised as:

IPO Allotted: when full shares/stocks allotted against applied.
IPO Partly/ partially allotted: This means less number of shares/stocks allotted against applied.
IPO Non- Allotment: No shares/Stocks allotted. 

 

What could be the reasons for non-allotment of an IPO?

•    The issue price is higher than the bid price
•    The application was not selected in the lottery process
•    Error in some of the details like pan card number, Demat Account number
•    More than one application has been submitted via the same pan card number

 

Also ReadHow to Increase the Chances of IPO Allotment

 

You can either check your allotment status on the BSE website or the IPO registrar, Link Intime. Here are the steps.

Checking the allotment status of CarTrade Tech on BSE website

Visit the BSE link for the IPO allotment by clicking on the link below https://www.bseindia.com/investors/appli_check.aspx 

Cartrade IPO Allotment

Once you reach the page, here are the steps to follow.
•    Under Issue Type – Select Equity Option
•    Under Issue Name – Select CarTrade Tech IPO from the drop-down box
•    Enter the Application Number exactly as in the acknowledge slip
•    Enter the PAN (10-digit alphanumeric) number
•    Once this is done, you need to click on the Captcha to verify that you are not a robot
•    Finally click on the Search Button

The allotment status will be displayed on the screen in front of you informing you about the number of stocks of CarTrade Tech allotted to you.

Checking the allotment status of CarTrade Tech on Link Intime (Registrar to IPO)

Visit the Link Intime registrar website for IPO status by clicking on the link: https://linkintime.co.in/MIPO/Ipoallotment.html

This dropdown will only show the active IPOs, so once the allotment status is finalized, you can select CarTrade Tech from the drop down box.

•    There are 3 options. You can either access the allotment status based on PAN, Application Number or DPID-Client ID combination.

•    Select the appropriate option you want to use and enter the details (PAN / Application Number / DPID-Client ID)

•    Finally, click on the Search button

The IPO status with number of shares of CarTrade Tech allotted will be displayed on the screen.